GBS is an acute peripheral neuropathy with a 5% mortality; 20% patients need mechanical ventilation, while one-third remain unable to walk independently after 6 months of disease onset

Early recognition of the need of mechanical ventilation and prognostic factors of poor outcome are important for GBS patients

Prognostic models of GBS were developed based on patients in western countries, but the validity of these models in Chinese patients remains unclear

We found EGRIS and mEGOS were good prognostic models for GBS patients in China and surprisingly found no difference between subtypes and outcomes

Albumin level could be a good biomarker for the prediction of disease severity and outcomes in GBS